John T. Blake serves as Executive at aTYR PHARMA INC, where they oversee executive responsibilities. Since joining the company, John T. Blake has executed 4 insider transactions totaling $4.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 20, 2020 involved selling 809 shares valued at $4.4K.
John T. Blake currently holds 1,754 shares of aTYR PHARMA INC (LIFE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John T. Blake has been a net seller of LIFE stock. They have purchased $0 and sold $4.8K worth of shares.
John T. Blake's most recent insider trade was on Feb 20, 2020, when they sold 809 shares at $5.44 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 8, 2018 | LIFE | $4.8K | Sale | 1,402 | $3.40 | Discretionary |
| Feb 7, 2018 | LIFE | $0 | Option Exercise | 3,334 | $N/A | Discretionary |